Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederroche.com
Roche Media News
Get the latest updates from Roche Media News directly as they happen.
Follow now 318 followers
Latest posts
Last updated 3 days ago
Roche’s US subsidiary Genentech breaks ground on state-of-the-art manufacturing facility in North Carolina, USA
3 days ago
The $700 million project is part of Roche’s $50 billion investment in...
Roche’s Susvimo maintains vision over five years with two refills per year in people with neovascular age-related macular degeneration (nAMD)
27 days ago
Susvimo is the only continuous delivery treatment to provide reliable, long-term vision...
Roche presents new insights in Alzheimer’s disease research across its diagnostics and pharmaceutical portfolios at AAIC
about 1 month ago
Trontinemab’s Phase Ib/IIa Brainshuttle™ AD study continues to show rapid and robust...
Roche provides regulatory update on Elevidys™ gene therapy for Duchenne muscular dystrophy in the EU
about 1 month ago
EMA’s CHMP issued an opinion not to recommend Elevidys™ (delandistrogene moxeparvovec) for...
[Ad hoc announcement pursuant to Art. 53 LR] Roche continues strong momentum with 7% growth (CER) in the first half of 2025
about 1 month ago
Basel, 24 July 2025 Group sales grew by 7%1 at constant exchange...
Roche receives CE Mark for minimally invasive blood test to help rule out Alzheimer’s disease
about 1 month ago
Elecsys pTau181 is the first In Vitro Diagnostic Regulation (IVDR) certified test...
European Commission approves Roche’s Itovebi for people with ER-positive, HER2-negative, advanced breast cancer with a PIK3CA mutation
about 1 month ago
Approval based on INAVO120 data showing the Itovebi™ (inavolisib)-based regimen more than...
Roche’s Board of Directors proposes exchange of Genussscheine for participation certificates (Partizipationsscheine)
about 1 month ago
Participation certificates (Partizipationsscheine) with a nominal value of CHF 0.001 each will...
[Ad hoc announcement pursuant to Art. 53 LR] Roche provides update on astegolimab in chronic obstructive pulmonary disease
about 1 month ago
The pivotal phase IIb ALIENTO study met the primary endpoint of a...
Changes to the Roche Enlarged Corporate Executive Committee
about 2 months ago
Basel, 30 June 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced...
Early data suggest Roche’s NXT007 may have the potential to provide haemostatic normalisation in people with haemophilia A
2 months ago
Positive phase I/II data presented at the 2025 International Society on Thrombosis...
Roche’s Lunsumio and Polivy combination significantly prolongs remission for people with relapsed or refractory large B-cell lymphoma
2 months ago
Pivotal phase III SUNMO study demonstrated an 11.5 month median progression-free survival...